Adlib Software: Accelerating Drug Development with Intelligent Data

Drug development has always been laborious and time consuming. When a pharmaceutical or life sciences company initiates the development process of a new drug, extensive clinical trials are held before the compound is submitted to the FDA for approval. However, the pathway to drug approval generates a massive amount of information. The enormous quantity of unstructured data generated during the trials from email, MS office documents, and other unstructured content formats has to be appropriately sorted into a standardized format before submitting it to the FDA. This task can be quite complex in terms of formatting and creating high-quality, searchable hyperlinks with navigation-rich content that could go into regulatory submission ready-pdfs for FDA approval.

Typically, a long stretch of tedious, paper-based process becomes imperative for documenting the whole journey of drug development. But gone are those days. Ontario based Adlib is now relieving pharma and life science companies of the burden of managing colossal data loads using its content intelligence platform to unlock intelligent data and fuel faster decisions—all while accelerating digital transformation.

With its ability to simplify the most complicated datasets and extract valuable data from highly diverse and complex document formats, Adlib helps pharma and life sciences companies turn their unstructured data into a premium, searchable PDF output with all the necessary navigation elements in it. Through its unique content intelligence platform, Adlib gathers the unstructured data and brings actionable insights to unearth emergent market opportunities and business lifelines. It enables reviewers to efficiently quicken the review process and accelerate the time to approve life-saving drugs. “Combining our decades of expertise in working with pharma and life sciences firms, we help them to unveil the latent intelligence inside their data to achieve seamless digital transformation,” says Scott Mackey, Founder and SVP Market Strategy at Adlib.

Leveraging cognitive technologies like AI and ML, the Adlib content intelligence platform executes human-like operations such as automatically grouping and classifying similar content and applying a rich set of metadata tags for easier data search.